Get the Stockscreener App
7.43
4.65%
0.33
Prothena Corporation Plc stock is traded at $7.43, with a volume of 1.66M.
It is up +4.65% in the last 24 hours and down -27.58% over the past month.
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
See More
Previous Close:
$7.10
Open:
$7.02
24h Volume:
1.66M
Relative Volume:
2.26
Market Cap:
$457.53M
Revenue:
$217.25M
Net Income/Loss:
$-50.92M
P/E Ratio:
-7.43
EPS:
-1
Net Cash Flow:
$-100.85M
1W Performance:
-12.59%
1M Performance:
-27.58%
6M Performance:
-58.02%
1Y Performance:
-66.23%
1-Day Range:
$6.92
$8.08
1-Week Range:
$6.92
$8.7996
52-Week Range:
$6.92
$25.42
Prothena Corporation Plc Stock (PRTA) Company Profile
Name
Prothena Corporation Plc
Sector
Industry
Phone
011-353-1-236-2500
Address
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Compare PRTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
7.43 | 457.53M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Jan-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Apr-24-23 | Initiated | SVB Securities | Outperform |
| Jan-27-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-28-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Jun-18-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-08-21 | Reiterated | Oppenheimer | Outperform |
| May-26-21 | Initiated | Citigroup | Buy |
| Feb-26-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-12-21 | Upgrade | Jefferies | Hold → Buy |
| Feb-02-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-20 | Initiated | H.C. Wainwright | Buy |
| Jul-09-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-19-19 | Upgrade | Evercore ISI | In-line → Outperform |
| May-21-18 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-23-18 | Downgrade | Jefferies | Buy → Hold |
| Apr-05-18 | Reiterated | Barclays | Overweight |
| Nov-20-17 | Downgrade | Wedbush | Outperform → Neutral |
| Sep-29-17 | Reiterated | BTIG Research | Buy |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Aug-17-17 | Initiated | Evercore ISI | Outperform |
| Jul-11-17 | Initiated | Jefferies | Buy |
| Apr-12-17 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-12-17 | Initiated | Piper Jaffray | Overweight |
| Mar-02-17 | Initiated | Instinet | Buy |
| Dec-21-16 | Initiated | SunTrust | Buy |
| Nov-03-16 | Initiated | Deutsche Bank | Buy |
| Aug-04-16 | Reiterated | Barclays | Overweight |
| May-13-16 | Initiated | Barclays | Overweight |
| Feb-19-16 | Reiterated | Wedbush | Outperform |
| Jan-21-16 | Initiated | Credit Suisse | Outperform |
View All
Prothena Corporation Plc Stock (PRTA) Latest News
Prothena Co. plc (NASDAQ:PRTA) Shares Bought by Dimensional Fund Advisors LP - Defense World
Prothena Corp (PRTA) Sees Price Target Reduction by HC Wainwrigh - GuruFocus
Prothena (PRTA) Price Target Reduced by H.C. Wainwright | PRTA S - GuruFocus
Prothena Corp (PRTA) Sees Price Target Reduction by HC Wainwright & Co. | PRTA Stock News - GuruFocus
Prothena Q1 Earnings Miss Estimates, Focus on Key Readouts in 2025 - Yahoo Finance
Prothena (PRTA) Price Target Adjusted, Outlook Remains Positive - GuruFocus
Prothena Corp (PRTA) Sees Price Target Adjusted by JMP Securities | PRTA Stock News - GuruFocus
Prothena Corp (PRTA) Receives Steady "Buy" Rating from Chardan Capital | PRTA Stock News - GuruFocus
RBC Trims Price Target on Prothena to $18 From $20, Keeps Sector Perform, Speculative Risk - marketscreener.com
Prothena (PRTA) Price Target Reduced by H.C. Wainwright | PRTA Stock News - GuruFocus
Is Prothena Corporation plc (PRTA) the Low Risk High Reward Stock Set to Triple by 2030? - Yahoo Finance
Prothena stock price target cut to $78 by Citizens JMP - Investing.com
Beyond The Numbers: 7 Analysts Discuss Prothena Corp Stock - Benzinga
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter - Benzinga
Prothena Co. plc (NASDAQ:PRTA) Receives $55.00 Consensus Price Target from Analysts - Defense World
10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey
Prothena Reports First Quarter 2025 Financial Results and Business Highlights - BioSpace
Prothena (PRTA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Prothena (PRTA) Expects Key Clinical Milestones and Financial Outlook for 2025 | PRTA Stock News - GuruFocus
Prothena Corporation PLC reports results for the quarter ended March 31Earnings Summary - TradingView
Prothena: Q1 Earnings Snapshot - marketscreener.com
Prothena Corp PLC Q1 2025 Earnings: EPS of -$1.12 Misses Estimates, Revenue Falls Short at $2.8 Million - GuruFocus
U.S. Transthyretin Amyloidosis Treatment Market Set to Witness - openPR.com
Prothena Corporation PLC expected to post a loss of 97 cents a shareEarnings Preview - TradingView
Insiders Re-Evaluate Their US$2.75m Stock Purchase As Prothena Falls To US$458m - Yahoo
Barclays PLC Buys 10,116 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Invesco Ltd. Purchases 1,632 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Corporation plc (PRTA) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Prothena Corporation plc (PRTA) did well last session? - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
Prothena Co. plc (NASDAQ:PRTA) Shares Sold by Wells Fargo & Company MN - Defense World
Prothena to Report First Quarter 2025 Financial Results on May 8 - BioSpace
Post-Trade Analysis: Prothena Corporation plc (PRTA) Slides -5.06, Closing at 9.20 - DWinneX
Legal & General Group Plc Reduces Stock Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena outlines potential multi-billion dollar opportunity with birtamimab launch by 2026 - MSN
Analytical Lens: Exploring Prothena Corporation plc (PRTA)’s Financial Story Through Ratios - DWinneX
It would be worthwhile to take a closer look at Prothena Corporation plc (PRTA) - uspostnews.com
Mariner LLC Has $4.76 Million Stock Position in Prothena Co. plc (NASDAQ:PRTA) - The AM Reporter
19,687 Shares in Prothena Co. plc (NASDAQ:PRTA) Bought by Franklin Resources Inc. - Defense World
JPMorgan Chase & Co. Purchases 187,364 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
(PRTA) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Vanguard Group Inc. Boosts Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Co. plc (NASDAQ:PRTA) Shares Bought by American Century Companies Inc. - Defense World
Norges Bank Invests $796,000 in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Raymond James Financial Inc. Acquires New Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Corebridge Financial Inc. Sells 1,596 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Co. plc (NASDAQ:PRTA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
KLP Kapitalforvaltning AS Purchases Shares of 12,900 Prothena Co. plc (NASDAQ:PRTA) - Defense World
Thrivent Financial for Lutherans Sells 8,889 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Teacher Retirement System of Texas Purchases Shares of 10,434 Prothena Co. plc (NASDAQ:PRTA) - Defense World
Benign Growth For Prothena Corporation plc (NASDAQ:PRTA) Underpins Stock's 26% Plummet - simplywall.st
Prothena Corporation Plc Stock (PRTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Prothena Corporation Plc Stock (PRTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 10% Owner |
May 06 '25 |
Sale |
7.64 |
1,984,053 |
15,164,712 |
5,304,596 |
| EcoR1 Capital, LLC | 10% Owner |
May 05 '25 |
Sale |
8.11 |
977,693 |
7,930,166 |
7,288,649 |
| SCULLY WILLIAM P | 10% Owner |
Jan 14 '25 |
Buy |
12.79 |
100,000 |
1,279,040 |
735,993 |
| SCULLY WILLIAM P | 10% Owner |
Dec 18 '24 |
Buy |
13.93 |
73,436 |
1,022,670 |
1,297,693 |
| SCULLY WILLIAM P | 10% Owner |
Dec 31 '24 |
Buy |
13.01 |
32,000 |
416,393 |
650,193 |
| SCULLY WILLIAM P | 10% Owner |
Dec 20 '24 |
Buy |
15.91 |
2,000 |
31,813 |
618,693 |
0.84%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):